Patients whose tumor samples showed higher OX-40 expression levels by density median score in the immune cells had a longer overall survival (OS) compared to those with low OX-40 expression (HR = 2.68 [95% CI 1.4–5.2], p = 0.002; Fig. 2a). Here, TNFRSF4 is linked to neoplasm.